Workplace productivity: A review of the impact of migraine and its treatment

PharmacoEconomics

Volumn 19, Issue 3, 2001, Pages 231-244

  Stang, Paul ^a   Cady, Roger ^b   Batenhorst, Alice ^c   Hoffman, Lynn ^a  

^a Primary Care Network ^*  (United States)

^b Primary Care Network   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST OF ILLNESS; DISABILITY; EMPLOYMENT; FUNCTIONAL DISEASE; HEADACHE; HEALTH CARE ORGANIZATION; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MIGRAINE; PREVALENCE; PRIORITY JOURNAL; PRODUCTIVITY; REVIEW; WORKPLACE;

COST OF ILLNESS; EFFICIENCY; EMPLOYMENT; HUMANS; MIGRAINE DISORDERS;

EID: 0035087338     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200119030-00002     Document Type: Review

References (72)

1. The impact of psychiatric disease on labor market outcomes
2. The economic impact of depression in the workplace
3. Depression in the workplace: An economic perspective
4. Economic consequences of illness in the workplace
5. Diagnosis and treatment of migraine
6. Prevention of migraine during prodrome with naratriptan
7. A pilot study to measure cognitive efficiency during migraine
8. Increasing incidence of medically recognized migraine headache in a United States population
9. Sumatriptan for the range of headaches in migraine sufferers: Results of the SPECTRUM Study
10. The treatment of mild headache in disabled migraine sufferers: Results of the spectrum study
11. Effect of early intervention with sumatriptan on migraine pain: Retrospective analysis of data from three clinical trials
12. The friction cost method for measuring indirect costs of disease
13. Anatomy of the healthy worker effect: A critical review
14. The measurement of social class in epidemiology
15. Migraine: Patterns of health care utilization
16. The economic cost of migraine: Present state of knowledge
17. Burden of migraine: A review of its socioeconomic impact
18. The economic burden of migraine to society
19. Chronic care costs in managed care
20. Healthcare resource use and costs associated with migraine in a managed healthcare setting
21. Healthcare resource and lost labour costs of migraine headache in the US
22. Sumatriptan treatment for migraine in a health maintenance organization: Economic, humanistic, and clinical outcomes
23. Reduced labor force participation among primary care patients with headache
24. Indirect costs of migraine in a managed care population
25. Prediction of the psychosocial and behavioral outcomes of headache in primary care
26. Grading the severity of chronic pain
27. Validity of an illness severity measure for headache in a population sample of migraine suffers
28. Reliability of the migraine disability assessment score in a population-based sample of headache suffers
29. The incidence of migraine headaches: A population-based study in Olmsted County, MN
30. Prevalence of chronic migraine headaches - United States, 1980-1989
31. Impact of migraine in the United States: Data from the National Health Interview Survey
32. Burden of migraine in the United States: Disability and economic costs
33. The epidemiology of migraine headache
34. Psychiatric comorbidity in migraine
35. The impact of psychiatric disorders on work loss days
36. Comparative view of the socioeconomic impact of migraine versus low back pain
37. Quality of life and productivity in nurses reporting migraine
38. A population-based survey of the social and personal impact of headache
39. A new instrument to assess the long-term quality of life effects from migraine: Development and psychometric testing of the MSQOL
40. Work-related disability: Results from the American Migraine Study
41. Lost workdays and decreased work effectiveness associated with headache in the workplace
42. Migraine and reduced work performance: A population-based diary study
43. Impact of headache on sickness absence and utilization of medical services: A Danish population study
44. A Canadian population survey on the clinical, epidemiologic, and societal impact of migraine and tension-type headache, part II
45. A study of migraine and its effects in a working population
46. Loss of productivity and quality of life in migraine sufferers among French workers: Results from the GAZEL cohort
47. A multinational investigation of the impact of subcutaneous sumatriptan: III. Workplace productivity and nonworkplace productivity
48. Cost benefit of sumatriptan to an employer
49. Sumatriptan use in a large group-model health maintenance organization
50. Changes in resource use and outcomes for patients with migraine treated with sumatriptan
51. Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine
52. Sumatriptan and lost productivity time: A time series analysis of diary data
53. Improvements in health-related quality of life with sumatriptan treatment for migraine
54. Impact of oral sumatriptan on workplace productivity, health related quality of life, healthcare use, and patient satisfaction with medication in nurses with migraine
55. Sumatriptan injection reduces productivity loss during a migraine attack: Results of a double-blind, placebo-controlled trial
56. Reduction of labor costs associated with treating migraine in the workplace
57. Measuring the functional status and well-being of patients with migraine headache
58. Evolution of the measurement of quality of life in migraine
59. A multinational investigation of the impact of subcutaneous sumatriptan: II. Health related quality of life
60. Subcutaneous sumatriptan for the treatment of migraine: Humanistic, economic, and clinical consequences
61. Medical consultation for migraine: Results from the American Migraine Study
62. The diagnosis of headache in primary care: Factors in the agreement of clinical and standardized diagnoses
63. Organizational health: A new paradigm for occupational stress research
64. Cutting the costs of migraine: Role of the employee health unit
65. Migraine: A problem for employers and managed care plans